Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses. - Fauveau C; Lawendy E; Deforges J; Cochin S; Moreau B; Balloul JM; Erbs P; Jain S; Laverny G (Molecular therapy. Oncology, 2026)